Form 4 for BNTX BioNTech SE
Accepted 2026-09-08 16:10:39 ET · period of report 2026-09-03 · accession 0002123975-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-08 16:10 | 2026-09-03+ | BNTX | Sahin Ugur | CEO, 10% | S - Sale | $103.12 | -76.5K | 781.7K | -9% | -$7.89M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-03 | S | D | 45,000 | $102.85 | 813,209 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-09-04 | S | D | 31,500 | $103.52 | 781,709 | D | — | — |